Empowering personalized cancer immunotherapy using machine learning OncoImmunity is a Norwegian bioinformatics company offering machine-learning based software to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy. OncoImmunity?s software will facilitate effective patient selection for cancer immunotherapy, and identify optimal targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time-frame
Member count: 1-10

Investors 1